GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » PEG Ratio

Frontier Biotechnologies (SHSE:688221) PEG Ratio : 0.00 (As of Dec. 12, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Frontier Biotechnologies's PE Ratio without NRI is 0.00. Frontier Biotechnologies's 5-Year EBITDA growth rate is 0.70%. Therefore, Frontier Biotechnologies's PEG Ratio for today is 0.00.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Frontier Biotechnologies's PEG Ratio or its related term are showing as below:



SHSE:688221's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.95
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Frontier Biotechnologies PEG Ratio Historical Data

The historical data trend for Frontier Biotechnologies's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontier Biotechnologies PEG Ratio Chart

Frontier Biotechnologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial - - - - -

Frontier Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Frontier Biotechnologies's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Frontier Biotechnologies's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Frontier Biotechnologies's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Frontier Biotechnologies's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Frontier Biotechnologies's PEG Ratio falls into.



Frontier Biotechnologies PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Frontier Biotechnologies's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.70
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Frontier Biotechnologies  (SHSE:688221) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Frontier Biotechnologies PEG Ratio Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Frontier Biotechnologies Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122
Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines